Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Immunology Research is Scopus-indexed (Q1, CiteScore 12.6), WoS SCIE. Published by American Association for Cancer Research Inc..
Checked against the index lists dated .
ISSN 2326-6066Verify ISSN ↗2326-6074Verify ISSN ↗
Publisher: American Association for Cancer Research Inc.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cancer Research | 30 / 233 | 87th | Q1 |
| Immunology | 34 / 243 | 86th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q1, CiteScore 12.6.
Cancer Immunology Research is Q1 in Cancer Research (rank 30 of 233) and Q1 in Immunology (rank 34 of 243), by CiteScore 2025.
Cancer Immunology Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 12.6, which places it in quartile Q1 at the 87th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 3.480, quartile Q1, with an H-index of 157.
Cancer Immunology Research is published by American Association for Cancer Research Inc. Its print ISSN is 2326-6066 and its online ISSN is 2326-6074.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Cancer Immunology Research has an h-index of 173 and a 2-year mean of 2.39 citations per paper (OpenAlex). Its Scopus CiteScore is 12.6, quartile Q1. On 2-year citations it ranks #124 of 229 Scopus journals in Cancer Research.
Cancer Immunology Research published 451 papers in 2025; its busiest recent year was 2019 with 640. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 92 research articles (2026), authors are most often from United States (48.1%), China (18.1%) and United Kingdom (3.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.